TY - JOUR T1 - Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients JF - J Viral Hepat Y1 - 2019 A1 - Belperio, PS A1 - Shahoumian, TA A1 - Loomis, TP A1 - Backus, LI VL - 26 SP - 980-990 IS - 8 ER -